drugset / Trial / NCT01938235
Exenatide for Myocardial Protection During Reperfusion Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to assess the effect of exenatide on myocardial injury in patients undergoing emergent percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction or heart attack (STEMI).
Timeline
- Start
- 2014-02
- Primary completion
- 2017-07
- Completion
- 2018-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 1.2 ug | Intravenous |
| Subject | Exenatide | Peptide | 1.9 ug | Intravenous |